Pnc Financial Services Group, Inc. Avidity Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 377 shares of RNA stock, worth $11,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
377
Previous 452
16.59%
Holding current value
$11,234
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$341 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$338 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$289 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$275 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$261 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.55B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...